Metavone seeks ASX listing

03/10/2016 - 10:52

Bookmark

Upgrade your subscription to use this feature.

Perth-based biotechnology company Metavone hopes to list on the ASX next month after raising up to $5 million from investors in an initial public offering.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options